STALEY CAPITAL ADVISERS’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$494K Hold
1,405
0.02% 129
2025
Q4
$460K Hold
1,405
0.02% 137
2025
Q3
$396K Hold
1,405
0.02% 149
2025
Q2
$392K Buy
1,405
+25
+2% +$7.08K 0.02% 148
2025
Q1
$430K Hold
1,380
0.02% 145
2024
Q4
$360K Hold
1,380
0.02% 147
2024
Q3
$445K Buy
1,380
+45
+3% +$14.7K 0.02% 143
2024
Q2
$417K Sell
1,335
-25
-2% -$7.34K 0.02% 139
2024
Q1
$387K Hold
1,360
0.02% 147
2023
Q4
$392K Buy
1,360
+20
+1% +$5.45K 0.02% 140
2023
Q3
$360K Buy
1,340
+5
+0.4% +$1.25K 0.02% 140
2023
Q2
$296K Hold
1,335
0.02% 152
2023
Q1
$323K Hold
1,335
0.02% 148
2022
Q4
$351K Sell
1,335
-77
-5% -$20.6K 0.02% 133
2022
Q3
$318K Hold
1,412
0.02% 135
2022
Q2
$344K Hold
1,412
0.02% 130
2022
Q1
$342K Hold
1,412
0.02% 142
2021
Q4
$318K Sell
1,412
-100
-7% -$21.1K 0.02% 150
2021
Q3
$322K Hold
1,512
0.02% 145
2021
Q2
$369K Hold
1,512
0.02% 140
2021
Q1
$376K Buy
1,512
+627
+71% +$150K 0.02% 138
2020
Q4
$203K Buy
+885
New +$204K 0.01% 174

Other funds holding AMGN

STALEY CAPITAL ADVISERS's AMGN Position: Q1 2026 in Review

STALEY CAPITAL ADVISERS held its Amgen (AMGN) position steady in Q1 2026 at 1,405 shares worth $494K. The position accounts for 0.02% of the portfolio, ranked #129.

STALEY CAPITAL ADVISERS first reported a position in AMGN in Q4 2020 and has held it in 22 quarters since. 3,128 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • STALEY CAPITAL ADVISERS held 1,405 shares of Amgen worth $494K as of Q1 2026.
  • STALEY CAPITAL ADVISERS left its Amgen share count unchanged in Q1 2026.
  • Amgen made up 0.02% of STALEY CAPITAL ADVISERS's portfolio in Q1 2026, its #129 holding.
  • STALEY CAPITAL ADVISERS first reported a position in Amgen in Q4 2020 and has held it in 22 quarters since.
  • 3,128 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on STALEY CAPITAL ADVISERS's 13F filing for Q1 2026, filed 29 Apr 2026.